Company: SACH
Filing Date: 2025-04-30
Form Type: DEF 14A
Source: 0001104659-25-042273
Chunk: 42

Company: Sachem Capital Corp.
Filing Date: 2025-04-30
Form: DEF 14A
Chunk 42
---
.

| ​ | Total Outstanding Awards                                                                                                         | ​ | ​ | ​ | ​ | 420,558 | ​ | ​ |
| ​ | Total shares underlying outstanding options                                                                                      | ​ | ​ | ​ | ​ |       — | ​ | ​ |
| ​ | Weighted average exercise price of outstanding options (includes options that were previously subject to performance conditions) | ​ | ​ | ​ | ​ |       — | ​ | ​ |
| ​ | Weighted average remaining contractual life of outstanding options                                                               | ​ | ​ | ​ | ​ |       — | ​ | ​ |
| ​ | Total unvested shares                                                                                                            | ​ | ​ | ​ | ​ | 420,558 | ​ | ​ |
| ​ | Total shares available for grant                                                                                                 | ​ | ​ | ​ | ​ | 436,762 | ​ | ​ |

As of April 28, 2025, the closing price of our Common Shares as reported on the NYSE American was $1.05 per share. Based solely on the closing price of our Common Shares as reported by the NYSE American on April 28, 2025 and the maximum number of shares that would have been available for awards as of such date under the 2025 Plan of 2,936,762, the maximum aggregate market value of the Common Shares that could potentially be issued under the 2025 Plan is $3,083,600. Best Practices We recognize the dilutive impact of stock-based incentive awards on our shareholders. We strive to balance the impact of dilution with our need to attract and retain talent. As such, we have incorporated a number of shareholder-friendly practices into the 2025 Plan, including the following: • No Liberal Share Recycling . Shares retained by or delivered to the Company to pay the exercise price or purchase price of any awards, shares delivered to or withheld by the Company to pay withholding taxes related to any awards, and unissued shares resulting from the settlement of stock appreciation rights (“ SARs ”) in stock will all count against the 2025 Plan’s share reserve. Additionally, shares purchased by the Company in the open market using the proceeds of option exercises would not become available for issuance as future awards under the 2025 Plan. • No Repricing of Stock Options or Stock Appreciation Rights Without Shareholder Approval . The 2025 Plan prohibits, without shareholder approval, actions to reprice, replace, or repurchase options or SARs when the exercise price per share of an option or SAR exceeds